Offer - Urjas Oil for just ₹ 1 X
Methastar 0.125 mg Tablet is a prescription medicine that is available as a Tablet. It is primarily used for the treatment of Post Delivery Bleeding.
The optimal dosage of Methastar 0.125 mg Tablet is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
The side effects typically associated with Methastar 0.125 mg Tablet include Headache, Abdominal Pain, Hypertension. While these are the most often observed Methastar 0.125 mg Tablet side effects, there are can be others also. These have been listed below. These side effects of Methastar 0.125 mg Tablet are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Methastar 0.125 mg Tablet is Unknown for pregnant women and Unknown for women who are breastfeeding. Warnings related to Methastar 0.125 mg Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Methastar 0.125 mg Tablet is contraindicated in people with pre-existing medical conditions like High Blood Pressure as it can result in adverse effects. The section on Methastar 0.125 mg Tablet contraindications lists all such conditions.
Besides this, Methastar 0.125 mg Tablet may also have severe interaction with some medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Methastar 0.125 mg Tablet is considered safe while driving, and is addictive.
Methastar 0.125 mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Methastar 0.125 mg Tablet safe for pregnant women?
It is not known what effect Methastar will have on pregnant women, because no research work has been carried out on this till date.
Is the use of Methastar 0.125 mg Tablet safe during breastfeeding?
Due to lack of research work on this topic, the side effects of Methastar for breastfeeding women are not known.
What is the effect of Methastar 0.125 mg Tablet on the Kidneys?
Methastar rarely harms the kidneys.
What is the effect of Methastar 0.125 mg Tablet on the Liver?
The liver can be affected by Methastar. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Methastar only after medical advice.
What is the effect of Methastar 0.125 mg Tablet on the Heart?
Methastar may have severe effects on your heart, so do not take it without first consulting your doctor.
If you are suffering from any of the following diseases, you should not take Methastar 0.125 mg Tablet unless your doctor advises you to do so -
Is this Methastar 0.125 mg Tablet habit forming or addictive?
No, you will not get addicted to Methastar 0.125 mg Tablet.
Is it safe to drive or operate heavy machinery when consuming?
Methastar 0.125 mg Tablet will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, but consume Methastar 0.125 mg Tablet only on doctor's advice.
Is it able to treat mental disorders?
No, Methastar 0.125 mg Tablet cannot treat any kind of mental disorder.
Interaction between Food and Methastar 0.125 mg Tablet
There isn't any research available on the side effects of taking Methastar 0.125 mg Tablet with food.
Interaction between Alcohol and Methastar 0.125 mg Tablet
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Methastar 0.125 mg Tablet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Methergine® (methylergonovine maleate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 331-332
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 837-839